a substance being studied in the treatment of cancer. ct-322 may prevent the growth of new blood vessels that tumors need to grow and may kill cancer cells. it is a type of vascular endothelial growth factor receptor-2 (vegfr-2) inhibitor and a type of antiangiogenesis agent. also called angiocept and vegfr-2 inhibitor ct-322.